How to NavigateEcosystem ConnectDistinguished InvestigatorsGlobal ConferencesRLT EducationRLT ComponentsSponsorsTrial Stats
A Prospective Study on Investigating the Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy
Description:
This study aims to investigate the value of 68Ga-grazytracer in predicting the efficacy of immunotherapy for advanced hepatobiliary malignancies.
Sponsor:
Ruijin Hospital
Contacts:
Jiajia Hujiajiahu@shsmu.edu.cn
0086-13524945287
Government Study Link:
NCT06597539 - Click here to see study onClinicalTrials.gov
68Ga-grazytracer
Isotope(s):
Target(s):
- Granzyme B
